TriptoBIO ApS

Private limited companyCVR 43307495København ØActive

TriptoBIO ApS is a private limited company, based in København Ø, active in research and experimental development on natural sciences and engineering, founded in 2022. Equity was negative at the end of 2025 (−DKK 11.8m). The company made a loss in both 2024 and 2025, most recently DKK 4.2m. Operations are spread over 3 production units.

PDF report Compare

Key figures · financial year 2025

Gross profit−DKK 54,353+90.3% vs. 2024

Net profit−DKK 4.2m+6.1% vs. 2024

Equity−DKK 11.8m−54.6% vs. 2024

Employees4latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

The loss got smaller: from DKK 4.4m to DKK 4.2m (2024 → 2025).

Employees

4 fewer employees than a year earlier: 4 (07/2026) against 8 (07/2025).

Registrations, last 24 months

06/10/2025: Moved to Fruebjergvej 3, 2100 København Ø
01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2022–2025 · amounts in DKK thousand

Equity and net profit

EquityNet profit

Financial figures for TriptoBIO ApS
	2022	2023	2024	2025	Change
Revenue	not stated	not stated	not stated	not stated	–
Gross profit	131	−855	−563	−54	+90.3%
Operating profit (EBIT)	−4	−3,591	−4,913	−4,241	+13.7%
Profit before tax	−21	−4,118	−5,704	−5,353	+6.1%
Net profit	−21	−3,212	−4,449	−4,176	+6.1%
Total assets	8,190	10,720	7,590	11,752	+54.8%
Equity	19	−3,193	−7,642	−11,818	−54.6%
Liabilities	8,171	13,913	15,232	23,569	+54.7%
Cash and cash equivalents	8,147	9,079	5,327	4,353	−18.3%
Average number of employees	2	5	5	5	0%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

Compare with the industry (431 companies)

Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures

Negative equity
Equity was −DKK 11.8m at the end of 2025.
How is this calculated?
Equity in the latest annual report is below zero.
Loss for 4 years in a row
Net result has been negative in 2022–2025.
How is this calculated?
Net result is negative in the two or more latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

4 financial years

Annual reports for TriptoBIO ApS
Financial year	Period	Published	Figures for	Documents
2025	01/01/2025 – 31/12/2025	05/07/2026	The company	PDF not statedXBRL
2024	01/01/2024 – 31/12/2024	01/07/2025	The company	PDF XBRL
2023	01/01/2023 – 31/12/2023	27/06/2024	The company	PDF XBRL
2022	30/05/2022 – 31/12/2022	03/07/2023	The company	PDF XBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR

Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profit−DKK 54,353No. 267 of 421

Better than 37% of the companies in the industry

Equity−DKK 11.8mNo. 407 of 431

Better than 6% of the companies in the industry

Number of employees4No. 203 of 431

Better than 53% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form

Rank among similar companies
Group	Gross profit	Equity
Companies with fewer than 20 employees69,967 companies in the comparison	No. 65,096of 69,742 Better than 7%	No. 69,647of 69,964 Better than 0%
Same industry and fewer than 20 employees329 companies in the comparison	No. 192of 323 Better than 41%	No. 315of 329 Better than 4%
Companies that are founded within the last five years16,662 companies in the comparison	No. 15,540of 16,614 Better than 6%	No. 16,603of 16,661 Better than 0%
All companies of type ApS66,508 companies in the comparison	No. 62,542of 66,379 Better than 6%	No. 66,188of 66,505 Better than 0%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering

Gross profit

TriptoBIO ApS−DKK 54,353
Carlsberg A/SDKK 40.2bn
Zealand Pharma A/SDKK 9.2bn

Net profit

TriptoBIO ApS−DKK 4.2m
Carlsberg A/SDKK 7bn
Zealand Pharma A/SDKK 6.5bn

Equity

TriptoBIO ApS−DKK 11.8m
Carlsberg A/SDKK 30.7bn
Zealand Pharma A/SDKK 14.8bn

Employees

TriptoBIO ApS4
Carlsberg A/S107
Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register

Owners

JRC Holding HL ApS50%
Jar ApS50%

TriptoBIO ApS

Subsidiaries and ownership shares

TriptoBIO R&D ApS100%

Subsidiaries are shown only if they are in the database.

Management

4 active registrations

Executive management

Executive management at TriptoBIO ApS
Name	Role	Appointed
Jon Rune Christensen	Director	30/05/2022
Johan Andersen-Ranberg	Director	30/05/2022

Board of directors

Board of directors at TriptoBIO ApS
Name	Role	Appointed
Jon Rune Christensen	Board member	29/07/2023
Johan Andersen-Ranberg	Board member	29/07/2023

Auditor: Buus Jensen I/S Statsautoriserede Revisorer
Founders: JRC Holding HL ApS, Jar ApS

Signing rule: Selskabet tegnes af den samlede bestyrelse eller af Johan Andersen-Ranberg og Jon Rune Christensen i forening.

Address and production units

3 active production units

Fruebjergvej 3
2100 København Ø

København Municipality · Postcode 2100

Other companies at the address (8)

Vektor Ejendomme A/SBuying and selling of own real estate
Symbion A/SRenting of commercial property
Synopsys Denmark ApSComputer consultancy and computer facilities management
Clinical-Microbiomics A/SResearch and experimental development on natural sciences and engineering
River Stone Biotech ApSResearch and experimental development on natural sciences and engineering

Production units
Production unit	Address	Industry	Employees	P number
TriptoBIO ApS	Fruebjergvej 3, 2100 København Ø	Research and experimental development on natural sciences and engineering	5	1028308430
TriptoBIO ApS v/ KU PLEN	Thorvaldsensvej 40, 1871 Frederiksberg C	Research and experimental development on natural sciences and engineering	4	1029331517
TriptoBIO ApS v/ KU ILF	Jagtvej 162, 2100 København Ø	Research and experimental development on natural sciences and engineering	1	1029874715

Purpose

Selskabets formål er at drive forskning, udvikling, produktion og salg af biobaserede kemikalier samt andre efter bestyrelsens skøn hermed beslægtede formål.

The purpose is quoted from the register in Danish.

Changes year by year

14 registered events

62022

32023

12024

32025

12026

20261 changeaccounts 1

05/07AccountsAnnual report for 2025 published

20253 changesaddress 1 · accounts 1 · industry 1

06/10AddressMoved to Fruebjergvej 3, 2100 København Ø
01/07AccountsAnnual report for 2024 published
01/01IndustryIndustry changed to Research and experimental development on natural sciences and engineering (721000)

20241 changeaccounts 1

27/06AccountsAnnual report for 2023 published

20233 changesmanagement 2 · accounts 1

29/07ManagementJon Rune Christensen appointed board member
29/07ManagementJohan Andersen-Ranberg appointed board member
03/07AccountsAnnual report for 2022 published

20226 changesaddress 1 · founded 1 · management 2 · ownership 2

18/09AddressMoved to Ole Maaløes Vej 3, 2200 København N
30/05FoundedRegistered as TriptoBIO ApS
30/05ManagementJon Rune Christensen appointed director
30/05ManagementJohan Andersen-Ranberg appointed director
30/05OwnershipJRC Holding HL ApS registered as owner (50%)
30/05OwnershipJAR ApS registered as owner (50%)

Related companies

Same industry in København

Genmab A/S676 employees
3shape A/S518 employees
Carlsberg A/S107 employees
IQVIA RDS Denmark A/S100 employees
Nuevolution A/S100 employees
Sunshine Enterprise Holding A/S73 employees

See all →

Same people in management

Hafnium Labs ApSvia Jon Rune Christensen
Hafnium Labs Q-props ApSvia Jon Rune Christensen
TriptoBIO R&D ApSvia Johan Andersen-Ranberg

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVR Report a correction